Pogleo 10mg (Dapagliflozin Propanediol Hydrate)

Adult dose

The recommended dosage for this medication is 10 mg once daily for monotherapy and additional combination therapy. For initial combination therapy with metformin, the dosage is either 5 mg or 10 mg once daily. It can be taken orally at any time of the day regardless of food intake, and the tablet should be swallowed whole.

Child dose

The efficacy and safety of dapagliflozin in pediatric patients under the age of 18 have not been established.

This medication should not be administered to certain patients. For example, patients allergic to the ingredients or additives of this medication, patients with type 1 diabetes, patients with diabetic ketoacidosis, and patients with genetic issues such as lactase deficiency or galactose intolerance, as well as patients undergoing dialysis, may be at risk if they take this medication. Caution is required when administering to patients with reduced fluid volume or poor kidney function. This medication can lower blood pressure or affect kidney function; therefore, especially elderly patients or those taking diuretics should frequently monitor fluid status and kidney function. During the use of this medication, genital infections or urinary tract infections may occur; if symptoms appear, medical consultation should be sought immediately. Additionally, hypoglycemic symptoms may manifest; when taken in combination with insulin or other blood sugar-lowering agents, dosage adjustments may be necessary to reduce the risk of hypoglycemia. This medication is not recommended for women who are pregnant or breastfeeding. If pregnancy is confirmed, the medication should be discontinued immediately, and it should not be used while breastfeeding. In case of overdose, there is no specific antidote, and appropriate treatment should be provided based on symptoms; this medication is not removed by dialysis. This medication does not significantly affect the ability to drive or operate machinery, but caution should be exercised due to the risk of hypoglycemia. Finally, this medication should be kept out of reach of children and stored in its original container.

Serious side effects

Urticaria, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with high fever, blisters, peeling skin, pain in mucous membranes of the mouth/eyes, difficulty breathing or shortness of breath, asthma attack, respiratory disturbances accompanied by cough and fever, jaundice (yellowing of the skin or eyes), extreme lethargy, sudden and severe headache, thunderclap headache, seizures, altered consciousness, visual disturbances, paralysis, urination

Mild side effects

• Vulvovaginitis
• balanitis and related genital infections
• urinary tract infection
• fungal infections
• hypoglycemia
• dry mouth
• dizziness
• constipation
• back pain
• dysuria

This medication should be stored in a tightly closed container to prevent exposure to air or moisture. It is advisable to maintain storage temperatures between 1°C and 30°C at room temperature. This storage method will safely preserve the medication's effectiveness.

Appearance

Yellow, double-sided, convex, diamond-shaped film-coated tablet

Package unit

Bottle packaging - 30 tablets/bottle, Bottle packaging - 90 tablets/bottle